Opsidio, a preclinical stage biotechnology company that develops novel biologic therapeutics for patients suffering from fibrotic and allergic diseases. Our lead candidate, OpSCF targets the unique form of Stem Cell Factor (SCF) that drives the cascade of pro fibrotic cytokines that may lead to organ failure and death.
| Website | http://www.opsidio.com |
| Employees | 4 (2 on RocketReach) |
| Founded | 2013 |
| Address | PO Box 802, Bryn Mawr, Pennsylvania 19010, US |
| Phone | +1 484-557-0698 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Biotechnology, Therapeutic Development, Preclinical Stage, Fibrotic Diseases, Allergic Diseases, Drug Development, Novel Therapeutics, Pharmaceutical Research, Biopharmaceutical, Clinical Trials, Life Sciences, Biologics, Immunology, Regenerative Medicine, Drug Discovery, Precision Medicine, Health Technology, Molecular Biology |
Looking for a particular Opsidio, LLC employee's phone or email?
Opsidio, LLC Questions
Martin Phillips is the CEO of Opsidio, LLC.
2 people are employed at Opsidio, LLC.
Opsidio, LLC is based in Bryn Mawr, Pennsylvania.
Top Opsidio, LLC Employees
-
Martin Phillips
CEO at Opsidio, LLC
Bryn Mawr, PA, US45+ -
Nicholas Lukacs
CSO at Opsidio, LLC
Ann Arbor, MI, US23
Related Companies
G2Crowd Trusted
300K+
Plugin Users
